Department of Nuclear Medicine, CHU de Bordeaux, Pessac, France
INRA, Nutrition et Neurobiologie Intégrée, UMR1286, Bordeaux, France
Search for other papers by J Brossaud in
Google Scholar
PubMed
INRA, Nutrition et Neurobiologie Intégrée, UMR1286, Bordeaux, France
Search for other papers by V Pallet in
Google Scholar
PubMed
Department of Nuclear Medicine, CHU de Bordeaux, Pessac, France
INRA, Nutrition et Neurobiologie Intégrée, UMR1286, Bordeaux, France
Search for other papers by J-B Corcuff in
Google Scholar
PubMed
the interaction between vitamin A and glucocorticoid action may occur downstream of adrenal hormone production as vitamin A and glucocorticoid receptors may interact directly or indirectly. As a consequence, RA is for instance able to decrease
Search for other papers by Elizabeth Micks in
Google Scholar
PubMed
Search for other papers by Greta B Raglan in
Google Scholar
PubMed
Department of Obstetrics and Gynecology, Department of Research, University of Washington, Box 356460, 1959 NE Pacific Street, Seattle, Washington, USA
Search for other papers by Jay Schulkin in
Google Scholar
PubMed
steroid receptors first appeared in living organisms approximately half a billion years ago. The mineralocorticoid, glucocorticoid, progesterone, and androgen receptors are very closely related members of the nuclear-receptor super-family, thought to arise
Laboratory for Anthropology and Skeletal Biology, Institute of Anatomy, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Search for other papers by Petar Milovanovic in
Google Scholar
PubMed
Search for other papers by Björn Busse in
Google Scholar
PubMed
status. Nevertheless, a number of observational or experimental studies showed the effects of hormones on osteocyte apoptosis and viability ( Table 1 ). Numerous articles reported that glucocorticoid excess increases osteocyte apoptosis both in human bone
Search for other papers by Jana Ernst in
Google Scholar
PubMed
Search for other papers by Katharina Gert in
Google Scholar
PubMed
Search for other papers by Frank Bernhard Kraus in
Google Scholar
PubMed
Search for other papers by Ulrike Elisabeth Rolle-Kampczyk in
Google Scholar
PubMed
Search for other papers by Martin Wabitsch in
Google Scholar
PubMed
Search for other papers by Faramarz Dehghani in
Google Scholar
PubMed
Search for other papers by Kristina Schaedlich in
Google Scholar
PubMed
, cytochrome P450 aromatase; ERα and ERβ , estrogen receptor alpha and beta; GLUT4 , glucose transporter 4; GPER , G protein-coupled estrogen receptor 1; GR , glucocorticoid receptor; HSD11B1 , 11beta-hydroxysteroid dehydrogenase 1; HSD17b5 , 17beta
Search for other papers by S E Baldeweg in
Google Scholar
PubMed
Search for other papers by S Ball in
Google Scholar
PubMed
Search for other papers by A Brooke in
Google Scholar
PubMed
Search for other papers by H K Gleeson in
Google Scholar
PubMed
Search for other papers by M J Levy in
Google Scholar
PubMed
Search for other papers by M Prentice in
Google Scholar
PubMed
Search for other papers by J Wass in
Google Scholar
PubMed
Search for other papers by the Society for Endocrinology Clinical Committee in
Google Scholar
PubMed
and medication independently, especially in an environment with which they are not familiar. Patients with CDI who require hydrocortisone, prednisolone or other glucocorticoid replacement because of wider hypopituitarism require increased doses and
Search for other papers by Rebeca Esquivel-Zuniga in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
delay in HPG axis maturation due to an associated condition, such as obesity, inflammatory bowel disease or anorexia nervosa and/or medications such as opioids or glucocorticoids ( 7 , 8 ). CDGP and FHH are found most often in boys, but
Division of Endocrinology, Division of Nephrology, Endocrine Research Laboratory, Department of Medicine
Division of Endocrinology, Division of Nephrology, Endocrine Research Laboratory, Department of Medicine
Division of Endocrinology, Division of Nephrology, Endocrine Research Laboratory, Department of Medicine
Search for other papers by Hershel Raff in
Google Scholar
PubMed
Search for other papers by Hariprasad Trivedi in
Google Scholar
PubMed
decreased sensitivity to glucocorticoid-negative feedback assessed by dexamethasone suppression (10) . That study did not take into account potential differences in dexamethasone absorption and metabolism nor did it evaluate physiological glucocorticoid
Search for other papers by Andrea V Haas in
Google Scholar
PubMed
Search for other papers by Paul N Hopkins in
Google Scholar
PubMed
Search for other papers by Nancy J Brown in
Google Scholar
PubMed
Search for other papers by Luminita H Pojoga in
Google Scholar
PubMed
Search for other papers by Jonathan S Williams in
Google Scholar
PubMed
Search for other papers by Gail K Adler in
Google Scholar
PubMed
Search for other papers by Gordon H Williams in
Google Scholar
PubMed
Introduction It is well established that individuals with Cushing’s syndrome, a disease of excess glucocorticoid production, have increased rates of hypertension, obesity, type 2 diabetes and cardiovascular (CV) events ( 1 ). Likewise
Search for other papers by Lang Qin in
Google Scholar
PubMed
Search for other papers by Xiaoming Zhu in
Google Scholar
PubMed
Search for other papers by Xiaoxia Liu in
Google Scholar
PubMed
Search for other papers by Meifang Zeng in
Google Scholar
PubMed
Search for other papers by Ran Tao in
Google Scholar
PubMed
Search for other papers by Yan Zhuang in
Google Scholar
PubMed
Search for other papers by Yiting Zhou in
Google Scholar
PubMed
Shanghai Pituitary Tumor Center, Shanghai, China
Search for other papers by Zhaoyun Zhang in
Google Scholar
PubMed
Search for other papers by Yehong Yang in
Google Scholar
PubMed
Search for other papers by Yiming Li in
Google Scholar
PubMed
Shanghai Pituitary Tumor Center, Shanghai, China
Search for other papers by Yongfei Wang in
Google Scholar
PubMed
Search for other papers by Hongying Ye in
Google Scholar
PubMed
Introduction Hypertension is a common chronic condition in patients with Cushing’s disease (CD) and may be the first sign ( 1 ). The pathogenesis of glucocorticoid-induced hypertension is not fully understood. It is thought to be related in
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Search for other papers by Elisa Selmin in
Google Scholar
PubMed
Search for other papers by Chiara Sabbadin in
Google Scholar
PubMed
Search for other papers by Miriam Dalla Costa in
Google Scholar
PubMed
Search for other papers by Giorgia Antonelli in
Google Scholar
PubMed
Search for other papers by Mario Plebani in
Google Scholar
PubMed
Search for other papers by Mattia Barbot in
Google Scholar
PubMed
Search for other papers by Corrado Betterle in
Google Scholar
PubMed
Search for other papers by Marco Boscaro in
Google Scholar
PubMed
Search for other papers by Carla Scaroni in
Google Scholar
PubMed
). Furthermore, the clinical picture of SAI may be complicated by the association of other pituitary deficiencies, which could affect both HPA axis and glucocorticoid (GC) treatment ( 5 ). A more severe degree of AI could characterize PAI, due to the impairment